Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Medical Engineered Material Market by Type (Medical Plastics, Medical Foams, Medical Films, Medical Adhesives, Medical Elastomer) and by Application (Medical Devices, Medical Disposable, Medical Wearable, Advanced Woundcare): Global Opportunity Analysis and Industry Forecast, 2023-2032

A15842

Pages: NA

Charts: NA

Tables: NA

Medical engineered materials (MEM) are materials used in the manufacture of medical products and services such as devices, disposables, and so on. These materials are intended for use in the production, safety, and construction of medical equipment. These are high-value-added materials that always exceed typical materials, resulting in lighter goods, have broader service temperature ranges, with multipurpose use, or have better life-cycle performance.

Medical engineered materials are applicable in medical disposables, medical devices, advanced wound care, and medical wearable.

COVID-19 Impact Analysis

  • Due to the COVID-19, there has been an increase in demand for personal protective equipment (PPE) kits, masks, drapes, and gloves. Capacity shortages have compelled healthcare facilities to upgrade and extend their infrastructure to fulfill the needs of rising patient intake. PPE kits and masks are in high demand from all sectors of the medical industry, as well as from the general public.
  • Due to a scarcity of medical masks, goggles, gowns, aprons, gloves, respirators, doctors, nurses, and other frontline personnel were critically under-equipped to care for COVID-19 patients. Companies have been working hard to supply the necessary number of masks and other supplies for healthcare professionals. For example, in March 2020, Apple (US) gave 2 million masks to the US. Similarly, Microsoft has distributed 15,000 pairs of safety goggles, as well as medical hats, infrared thermometers, and protective suits to countries throughout the world.
  • During the pandemic, medical gadgets such as patient care systems, thermal scanners, and related equipment will increase at a greater rate than others. Ventilators are crucial tools in the fight against the coronavirus, which demands a faster supply of raw materials including plastics, adhesives, and elastomers, as well as proper and timely logistical support and regulatory permissions. Diagnostic instruments and gadgets, such as thermal scanners, which are used to detect and monitor medical disorders, are also in high demand due to their importance in determining disease beginnings.

Top Impacting Factors

Medical equipment and devices are utilized in a variety of procedures, surgical purposes, and diagnostic. These gadgets and equipment are made with medical-designed materials. Demographic trends, such as an aging population and novel disease strains, are boosting demand for engineered materials in medical equipment. Globally, the aging population has a considerable impact on product design and manufacturing. New materials, such as soft-touch thermoplastic elastomers (TPE), and methods, such as over-molding, are among the new advancements that are expected to boost demand for medical engineered materials. Some of the restraints on the medical engineered materials market include government control over medical device prices, varying regulations, and moment approval processes.

Governments control the costs of healthcare facilities to ensure that they are accessible to everybody. This price pressure exists at all points along the value chain. As a result, medical device manufacturers and raw material suppliers must keep costs under control. 

This diminishes these players profit margins while also reforming their costs. The international healthcare industry is highly regulated. Medical device approval authorities assess device safety and performance in a variety of ways and issue product clearance in a variety of time frames. Medical waste is defined as garbage containing infectious materials. Waste generated by healthcare facilities such as medical research centers, veterinary clinics, hospitals, and labs is included. Plastics account for a sizable portion of the medical waste generated. On mostly yet another side, the transition to disposables has expanded the usage of plastics, but it is also generating more plastic garbage. Some single-use devices can be reused after being reprocessed. Consequently, the fear of infected products caused by improperly disinfected products leads to their destruction. Although manufacturers have begun to recycle plastics, the waste remains a significant challenge for the medical engineered materials business.


Market Trends

  • The Asia-Pacific region is expected to be the fastest-growing market for medical engineered materials. The Asia-Pacific medical engineered materials market is being driven by a growing population, a higher need for improved healthcare establishments, and a growth in lifestyle-related disorders.
  • China is the region's largest market for medical engineered materials. Because of its large manufacturing base, China is also a key producer and consumer of medical engineered materials in the region. Aside from India, South Korea, China, and Japan are expected to rise rapidly.
  • Further, the rising inclusion of digitalization and other sophisticated technologies such as 3D printing for the manufacturing of medical equipment is responsible for the market's rapid expansion in this category.
  • Market players are adopting many strategies such as R&D activities, acquisitions, mergers, contracts, new product launches, agreements, and partnerships to expand their business.
  • Evonik introduced a new RESOMER composites product line in April 2018. These bioresorbable polymers improve application development and enhance speedier patient recovery.
  • SABIC debuted its Polycarbonate (PC) based on certified renewable feedstock in October 2019, offering SABIC and its clients a solution that has the potential to minimize CO2 emissions as well as the usage of fossil feedstock during production. The certified PC resin can be used in a variety of market categories, including automotive, consumer, electronics and electrical, building and construction, and healthcare.
  • BASF's fiscal year ends in June 2020. The business spent USD 10 billion to build a verbund facility in Zhanjiang, Guangdong. The factories will manufacture tailored plastics and thermoplastic polyurethane (TPU) to meet the growing demands of various development industries in southern China and beyond Asia.
  • Covestro plans to invest in a new construction line in Thailand to create polycarbonate films in October 2020. The company's position in Asia-Pacific is likely to improve as a result of this investment.

Key Benefits of the Report

  • This study presents the analytical depiction of the medical engineered material industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the medical engineered material market share.
  • The current market is quantitatively analyzed to highlight the medical engineered material market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed medical engineered material market analysis based on competitive intensity and how the competition will take shape in coming years

Questions Answered in the Medical Engineered Material Market Report

  • Who are the leading market players active in the medical engineered material market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?

Key Market Segments

  • By Type
    • Medical Plastics
    • Medical Foams
    • Medical Films
    • Medical Adhesives
    • Medical Elastomer
  • By Application
    • Medical Devices
    • Medical Disposable
    • Medical Wearable
    • Advanced Woundcare
  • By Region
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia-Pacific
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Rest of Europe
    • LAMEA
      • Saudi Arabia
      • South Africa
      • Brazil
      • Rest of LAMEA


Key Market Players

  • Arkema SA
  • Solvay SA
  • Celanese Corporation
  • PolyOne Corporation
  • Principality Medical Supplies
  • Covestro AG
  • SABIC
  • Axiom Materials, Inc.
  • Eastman Chemical Company
  • W. L. Gore & Associates, Inc.
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: MEDICAL ENGINEERED MATERIAL MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Medical Plastics

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Medical Foams

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Medical Films

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Medical Adhesives

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Medical Elastomer

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: MEDICAL ENGINEERED MATERIAL MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Medical Devices

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Medical Disposable

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Medical Wearable

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Advanced Woundcare

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: MEDICAL ENGINEERED MATERIAL MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Medical Engineered Material Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By Application
      • 6.2.6. Canada Medical Engineered Material Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By Application
      • 6.2.7. Mexico Medical Engineered Material Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By Application
    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Medical Engineered Material Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By Application
      • 6.3.6. Germany Medical Engineered Material Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By Application
      • 6.3.7. Italy Medical Engineered Material Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By Application
      • 6.3.8. Spain Medical Engineered Material Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By Application
      • 6.3.9. UK Medical Engineered Material Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By Application
      • 6.3.10. Russia Medical Engineered Material Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By Application
      • 6.3.11. Rest Of Europe Medical Engineered Material Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By Application
    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Medical Engineered Material Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By Application
      • 6.4.6. Japan Medical Engineered Material Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By Application
      • 6.4.7. India Medical Engineered Material Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By Application
      • 6.4.8. South Korea Medical Engineered Material Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By Application
      • 6.4.9. Australia Medical Engineered Material Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By Application
      • 6.4.10. Thailand Medical Engineered Material Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By Application
      • 6.4.11. Malaysia Medical Engineered Material Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By Application
      • 6.4.12. Indonesia Medical Engineered Material Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By Application
      • 6.4.13. Rest of Asia Pacific Medical Engineered Material Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By Application
    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Medical Engineered Material Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By Application
      • 6.5.6. South Africa Medical Engineered Material Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By Application
      • 6.5.7. Saudi Arabia Medical Engineered Material Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By Application
      • 6.5.8. UAE Medical Engineered Material Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By Application
      • 6.5.9. Argentina Medical Engineered Material Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By Application
      • 6.5.10. Rest of LAMEA Medical Engineered Material Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By Application
  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Covestro AG

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Arkema SA

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. W. L. Gore And Associates, Inc.

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Solvay SA

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. PolyOne Corporation

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. SABIC

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Eastman Chemical Company

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Celanese Corporation

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Principality Medical Supplies

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Axiom Materials, Inc.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL PLASTICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL FOAMS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL FILMS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL ADHESIVES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL ELASTOMER, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL DISPOSABLE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL WEARABLE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR ADVANCED WOUNDCARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA MEDICAL ENGINEERED MATERIAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 16. U.S. MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 17. U.S. MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 18. CANADA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 19. CANADA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 20. MEXICO MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 21. MEXICO MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 22. EUROPE MEDICAL ENGINEERED MATERIAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 23. EUROPE MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 24. EUROPE MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. FRANCE MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 26. FRANCE MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. GERMANY MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 28. GERMANY MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. ITALY MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 30. ITALY MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 31. SPAIN MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 32. SPAIN MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. UK MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 34. UK MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. RUSSIA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 36. RUSSIA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. REST OF EUROPE MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 38. REST OF EUROPE MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. ASIA-PACIFIC MEDICAL ENGINEERED MATERIAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 40. ASIA-PACIFIC MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 41. ASIA-PACIFIC MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. CHINA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 43. CHINA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. JAPAN MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 45. JAPAN MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. INDIA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 47. INDIA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. SOUTH KOREA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 49. SOUTH KOREA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. AUSTRALIA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 51. AUSTRALIA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 52. THAILAND MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 53. THAILAND MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. MALAYSIA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 55. MALAYSIA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 56. INDONESIA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 57. INDONESIA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. REST OF ASIA PACIFIC MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 59. REST OF ASIA PACIFIC MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 60. LAMEA MEDICAL ENGINEERED MATERIAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 61. LAMEA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 62. LAMEA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. BRAZIL MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 64. BRAZIL MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH AFRICA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH AFRICA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. SAUDI ARABIA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 68. SAUDI ARABIA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. UAE MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 70. UAE MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. ARGENTINA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 72. ARGENTINA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. REST OF LAMEA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 74. REST OF LAMEA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. COVESTRO AG: KEY EXECUTIVES
  • TABLE 76. COVESTRO AG: COMPANY SNAPSHOT
  • TABLE 77. COVESTRO AG: OPERATING SEGMENTS
  • TABLE 78. COVESTRO AG: PRODUCT PORTFOLIO
  • TABLE 79. COVESTRO AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 80. ARKEMA SA: KEY EXECUTIVES
  • TABLE 81. ARKEMA SA: COMPANY SNAPSHOT
  • TABLE 82. ARKEMA SA: OPERATING SEGMENTS
  • TABLE 83. ARKEMA SA: PRODUCT PORTFOLIO
  • TABLE 84. ARKEMA SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 85. W. L. GORE AND ASSOCIATES, INC.: KEY EXECUTIVES
  • TABLE 86. W. L. GORE AND ASSOCIATES, INC.: COMPANY SNAPSHOT
  • TABLE 87. W. L. GORE AND ASSOCIATES, INC.: OPERATING SEGMENTS
  • TABLE 88. W. L. GORE AND ASSOCIATES, INC.: PRODUCT PORTFOLIO
  • TABLE 89. W. L. GORE AND ASSOCIATES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 90. SOLVAY SA: KEY EXECUTIVES
  • TABLE 91. SOLVAY SA: COMPANY SNAPSHOT
  • TABLE 92. SOLVAY SA: OPERATING SEGMENTS
  • TABLE 93. SOLVAY SA: PRODUCT PORTFOLIO
  • TABLE 94. SOLVAY SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 95. POLYONE CORPORATION: KEY EXECUTIVES
  • TABLE 96. POLYONE CORPORATION: COMPANY SNAPSHOT
  • TABLE 97. POLYONE CORPORATION: OPERATING SEGMENTS
  • TABLE 98. POLYONE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 99. POLYONE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 100. SABIC: KEY EXECUTIVES
  • TABLE 101. SABIC: COMPANY SNAPSHOT
  • TABLE 102. SABIC: OPERATING SEGMENTS
  • TABLE 103. SABIC: PRODUCT PORTFOLIO
  • TABLE 104. SABIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 105. EASTMAN CHEMICAL COMPANY: KEY EXECUTIVES
  • TABLE 106. EASTMAN CHEMICAL COMPANY: COMPANY SNAPSHOT
  • TABLE 107. EASTMAN CHEMICAL COMPANY: OPERATING SEGMENTS
  • TABLE 108. EASTMAN CHEMICAL COMPANY: PRODUCT PORTFOLIO
  • TABLE 109. EASTMAN CHEMICAL COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. CELANESE CORPORATION: KEY EXECUTIVES
  • TABLE 111. CELANESE CORPORATION: COMPANY SNAPSHOT
  • TABLE 112. CELANESE CORPORATION: OPERATING SEGMENTS
  • TABLE 113. CELANESE CORPORATION: PRODUCT PORTFOLIO
  • TABLE 114. CELANESE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. PRINCIPALITY MEDICAL SUPPLIES: KEY EXECUTIVES
  • TABLE 116. PRINCIPALITY MEDICAL SUPPLIES: COMPANY SNAPSHOT
  • TABLE 117. PRINCIPALITY MEDICAL SUPPLIES: OPERATING SEGMENTS
  • TABLE 118. PRINCIPALITY MEDICAL SUPPLIES: PRODUCT PORTFOLIO
  • TABLE 119. PRINCIPALITY MEDICAL SUPPLIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. AXIOM MATERIALS, INC.: KEY EXECUTIVES
  • TABLE 121. AXIOM MATERIALS, INC.: COMPANY SNAPSHOT
  • TABLE 122. AXIOM MATERIALS, INC.: OPERATING SEGMENTS
  • TABLE 123. AXIOM MATERIALS, INC.: PRODUCT PORTFOLIO
  • TABLE 124. AXIOM MATERIALS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET
  • FIGURE 3. SEGMENTATION MEDICAL ENGINEERED MATERIAL MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MEDICAL ENGINEERED MATERIAL MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMEDICAL ENGINEERED MATERIAL MARKET
  • FIGURE 11. MEDICAL ENGINEERED MATERIAL MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL PLASTICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL FOAMS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL FILMS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL ADHESIVES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL ELASTOMER, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. MEDICAL ENGINEERED MATERIAL MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 18. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL DISPOSABLE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL WEARABLE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. MEDICAL ENGINEERED MATERIAL MARKET FOR ADVANCED WOUNDCARE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 26. COMPETITIVE DASHBOARD
  • FIGURE 27. COMPETITIVE HEATMAP: MEDICAL ENGINEERED MATERIAL MARKET
  • FIGURE 28. TOP PLAYER POSITIONING, 2024
  • FIGURE 29. COVESTRO AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 30. COVESTRO AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 31. COVESTRO AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 32. ARKEMA SA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. ARKEMA SA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. ARKEMA SA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. W. L. GORE AND ASSOCIATES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. W. L. GORE AND ASSOCIATES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. W. L. GORE AND ASSOCIATES, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. SOLVAY SA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. SOLVAY SA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. SOLVAY SA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. POLYONE CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. POLYONE CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. POLYONE CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. SABIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. SABIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. SABIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. EASTMAN CHEMICAL COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. EASTMAN CHEMICAL COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. EASTMAN CHEMICAL COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. CELANESE CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. CELANESE CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. CELANESE CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. PRINCIPALITY MEDICAL SUPPLIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. PRINCIPALITY MEDICAL SUPPLIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. PRINCIPALITY MEDICAL SUPPLIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. AXIOM MATERIALS, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. AXIOM MATERIALS, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. AXIOM MATERIALS, INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Medical Engineered Material Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue